Kary E. Thompson

1.6k total citations
36 papers, 1.1k citations indexed

About

Kary E. Thompson is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Kary E. Thompson has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Kary E. Thompson's work include Effects and risks of endocrine disrupting chemicals (8 papers), Reproductive Biology and Fertility (7 papers) and Pharmaceutical studies and practices (5 papers). Kary E. Thompson is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (8 papers), Reproductive Biology and Fertility (7 papers) and Pharmaceutical studies and practices (5 papers). Kary E. Thompson collaborates with scholars based in United States, Germany and Belgium. Kary E. Thompson's co-authors include Patricia B. Hoyer, David J. Dix, I.G. Sipes, John C Rockett, Patricia J. Christian, Vanesa Y. Rawe, Stephen A. Krawetz, Robert Goodrich, Lillian F. Strader and Adrian E. Platts and has published in prestigious journals such as Biological Psychiatry, Endocrinology and Hypertension.

In The Last Decade

Kary E. Thompson

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kary E. Thompson United States 19 315 284 225 203 119 36 1.1k
Muneeb A. Faiq India 19 299 0.9× 348 1.2× 350 1.6× 56 0.3× 101 0.8× 60 1.8k
Marek Koziorowski Poland 20 259 0.8× 245 0.9× 271 1.2× 190 0.9× 114 1.0× 108 1.2k
Chris Maloney Australia 24 281 0.9× 983 3.5× 71 0.3× 211 1.0× 82 0.7× 48 2.4k
Luı́s Casis Spain 21 167 0.5× 330 1.2× 229 1.0× 108 0.5× 16 0.1× 101 1.3k
Ayodeji Folorunsho Ajayi Nigeria 15 180 0.6× 240 0.8× 294 1.3× 86 0.4× 92 0.8× 80 1.2k
Damayanthi Durairajanayagam Malaysia 22 953 3.0× 426 1.5× 1.4k 6.2× 185 0.9× 126 1.1× 52 2.2k
Francisco Eduardo Martinez Brazil 19 104 0.3× 212 0.7× 222 1.0× 92 0.5× 29 0.2× 72 1.1k
Hassan W. Bakos Australia 15 720 2.3× 414 1.5× 1.1k 4.9× 131 0.6× 59 0.5× 32 1.9k
Steven E. Domino United States 28 198 0.6× 935 3.3× 179 0.8× 225 1.1× 460 3.9× 60 2.2k
Rémi Cadet France 16 242 0.8× 169 0.6× 396 1.8× 78 0.4× 35 0.3× 22 836

Countries citing papers authored by Kary E. Thompson

Since Specialization
Citations

This map shows the geographic impact of Kary E. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kary E. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kary E. Thompson more than expected).

Fields of papers citing papers by Kary E. Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kary E. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kary E. Thompson. The network helps show where Kary E. Thompson may publish in the future.

Co-authorship network of co-authors of Kary E. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Kary E. Thompson. A scholar is included among the top collaborators of Kary E. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kary E. Thompson. Kary E. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, Kary E., et al.. (2021). Pegbelfermin, a PEGylated FGF21 analogue, has pharmacology without bone toxicity after 1-year dosing in skeletally-mature monkeys. Toxicology and Applied Pharmacology. 428. 115673–115673. 9 indexed citations
2.
Thompson, Kary E., et al.. (2019). Allogeneic murine pregnancy models for assessing the developmental effects of immune‐stimulating antibodies: Challenges in reproducibility. Birth Defects Research. 111(16). 1178–1191. 3 indexed citations
3.
Scialli, Anthony R., George P. Daston, Connie L. Chen, et al.. (2018). Rethinking developmental toxicity testing: Evolution or revolution?. Birth Defects Research. 110(10). 840–850. 36 indexed citations
4.
Scialli, Anthony R., Graham P. Bailey, Bruce Beyer, et al.. (2016). Reprint of “Potential seminal transport of pharmaceuticals to the conceptus”. Reproductive Toxicology. 59. 22–30. 6 indexed citations
5.
Scialli, Anthony R., Graham P. Bailey, Bruce Beyer, et al.. (2015). Potential seminal transport of pharmaceuticals to the conceptus. Reproductive Toxicology. 58. 213–221. 16 indexed citations
6.
Thompson, Kary E., et al.. (2015). Assessment of cervical passage of vital dyes in pregnant, nonpregnant, and mated rats and mice. Reproductive Toxicology. 59. 1–7. 5 indexed citations
7.
Chen, Connie L., Bruce Beyer, William J. Breslin, et al.. (2014). Introduction to the HESI DART Drugs in Semen Consortium. Reproductive Toxicology. 48. 113–114. 5 indexed citations
8.
Hui, Julia, et al.. (2014). What fetal exposure/outcome could occur from drugs in semen? – Studies with metronidazole and thalidomide. Reproductive Toxicology. 48. 20–20. 2 indexed citations
9.
Carney, Edward W., Amy Ellis, Rochelle W. Tyl, et al.. (2011). Critical evaluation of current developmental toxicity testing strategies: a case of babies and their bathwater. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(5). 395–403. 21 indexed citations
10.
Dirikolu, Levent, et al.. (2008). Pharmacokinetics of gabapentin in horses. Journal of Veterinary Pharmacology and Therapeutics. 31(2). 175–177. 21 indexed citations
11.
Platts, Adrian E., David J. Dix, H Chemes, et al.. (2007). Success and failure in human spermatogenesis as revealed by teratozoospermic RNAs. Human Molecular Genetics. 16(7). 763–773. 207 indexed citations
12.
Lehner, Andreas F., et al.. (2007). Gabapentin in Horses: Validation of an Analytical Method for Gabapentin Quantitation. Journal of Analytical Toxicology. 31(9). 555–565. 9 indexed citations
13.
Rockett, John C, Michael G. Narotsky, Kary E. Thompson, et al.. (2006). Effect of conazole fungicides on reproductive development in the female rat. Reproductive Toxicology. 22(4). 647–658. 53 indexed citations
14.
Thompson, Kary E., et al.. (2004). Differences between rats and mice in the involvement of the aryl hydrocarbon receptor in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss. Toxicology and Applied Pharmacology. 203(2). 114–123. 34 indexed citations
15.
Hu, Xiaoming, Patricia J. Christian, Kary E. Thompson, I. Glenn Sipes, & Patricia B. Hoyer. (2001). Apoptosis Induced in Rats by 4-Vinylcyclohexene Diepoxide Is Associated with Activation of the Caspase Cascades1. Biology of Reproduction. 65(1). 87–93. 81 indexed citations
16.
Borman, Sherri, et al.. (1999). A Single Dose of the Ovotoxicant 4-Vinylcyclohexene Diepoxide Is Protective in Rat Primary Ovarian Follicles. Toxicology and Applied Pharmacology. 158(3). 244–252. 40 indexed citations
17.
Thompson, Kary E.. (1999). Modelling the Internalization of Labelled Cells in Tumour Spheroids. Bulletin of Mathematical Biology. 61(4). 601–623. 39 indexed citations
18.
Sacco, William P., et al.. (1993). Gender Differences in AIDS-Relevant Condom Attitudes and Condom Use. AIDS Education and Prevention. 5(4). 311–326. 72 indexed citations
19.
Wolkowitz, Owen M., Herbert Weingartner, David R. Rubinow, et al.. (1993). Steroid modulation of human memory: Biochemical correlates. Biological Psychiatry. 33(10). 744–746. 23 indexed citations
20.
Wiranowska, Marzenna, Thomas C. Wilson, Kary E. Thompson, & Leon D. Prockop. (1989). Cerebral Interferon Entry in Mice after Osmotic Alteration of Blood–Brain Barrier. Journal of Interferon Research. 9(3). 353–362. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muneeb A. Faiq Breakdown of academic impact, for papers by Marek Koziorowski Breakdown of academic impact, for papers by Chris Maloney Breakdown of academic impact, for papers by Luı́s Casis Breakdown of academic impact, for papers by Ayodeji Folorunsho Ajayi Breakdown of academic impact, for papers by Damayanthi Durairajanayagam Breakdown of academic impact, for papers by Francisco Eduardo Martinez Breakdown of academic impact, for papers by Hassan W. Bakos Breakdown of academic impact, for papers by Steven E. Domino Breakdown of academic impact, for papers by Rémi Cadet
Rankless by CCL
2026